2021 Biomedical Innovation Program to fund 4 OHSU projects

Biomedical awardees 2021

Childbirth outcomes, vascular disease, headaches and magnetic resonance imaging — these are targets of 2021 Biomedical Innovation Program funding in the device and diagnostic track.

This category of funding supports novel and innovative medical device and diagnostic technologies that address a significant clinical problem and aim to improve the quality of patient care, achieve cost savings, or improve research efficiency.

The awards provide funds, project management and mentorship to support researchers moving innovative technologies from laboratories toward and into the clinic.

Awardees

  • Xin Li, Ph.D., associate professor, Advanced Imaging Research Center
    “Improving practical activity MRI quantification”
  • Austin Peters, M.D., assistant professor
    Department of Anesthesiology & Perioperative Medicine, School of Medicine
    “Self-administered palate stimulation device for non-invasive headache relief”
  • Elise Erickson, Ph.D., CNM, assistant professor
    Midwifery Division, School of Nursing
    “Deciphering the due date-using AI to predict and improve childbirth”
  • David Warner, M.D., research resident, and Albert Lwin, M.D., M.P.H., research resident, and Cherrie Abraham, M.D., faculty sponsor
    Department of Surgery, School of Medicine
    “Novel vascular doppler device for blood flow detection”

The Oregon Clinical & Translational Research Institute, OHSU Collaborations & Entrepreneurship, and OHSU Technology Transfer jointly administer the Biomedical Innovation Program (BIP). Funding for BIP is made possible by OCTRI and the University Venture Development Fund. Interested donors are encouraged to email Timothy Coffey.

OCTRI is supported by (UL1TR002369) from the National Center for Advancing Translational Science at the National Institutes of Health.